Redefining Dual Antiplatelet Strategies After Acute Coronary Syndrome: Insights from Recent RCTs. [PDF]
He M +6 more
europepmc +1 more source
Comparison of clinical efficacy and bleeding risk between ticagrelor and clopidogrel in elderly patients after percutaneous coronary intervention: A retrospective study. [PDF]
Luo J, Liang G, Chen A.
europepmc +1 more source
Safety and Efficacy Comparison of Ticagrelor versus Other P2Y12 Inhibitors in Combination with Oral Anticoagulants as a Part of DAPT/SAPT in Patients with Concomitant Atrial Fibrillation and Coronary Artery Disease: A Meta-Analysis. [PDF]
Li Y, Gong J, Liu N.
europepmc +1 more source
Ticagrelor-induced sinus pause: an adenosine-driven side effect. [PDF]
Fanning JK +3 more
europepmc +1 more source
Intravenous cangrelor as rescue therapy for acute thrombosis in neuroendovascular procedures: illustrative cases. [PDF]
Sahin ME +4 more
europepmc +1 more source
CYP2C19 genotype-guided escalation to ticagrelor vs. clopidogrel in secondary stroke prevention: a retrospective cohort study. [PDF]
Haidong S, Min D, Hong Y, Jing Y.
europepmc +1 more source
Effect of insulin resistance on ticagrelor-versus clopidogrel-based dual antiplatelet therapy for secondary prevention of stroke in carriers of <i>CYP2C19</i> loss-of-function mutations. [PDF]
Zhao J +11 more
europepmc +1 more source
Comparative Efficacy of Ticagrelor and Clopidogrel in ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: A Cardiac Magnetic Resonance Imaging-Based Pilot Study. [PDF]
Wang WT +9 more
europepmc +1 more source
Efficacy and safety of off-label low-dose compared with standard-dose antiplatelet agents in patients with coronary heart disease: a meta-analysis. [PDF]
Zheng L +11 more
europepmc +1 more source

